Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ...
Historically, more prostate cancer patients have had a prostatectomy than any other treatment, since radiation as an ...
Medical Device Network on MSN2d
Telix’s prostate cancer imaging agent approved in BrazilBrazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...
Symptoms of prostate cancer may include needing to urinate more frequently; having to rush to the toilet; straining to ...
News Medical on MSN1d
AI could play a key role in improving prostate cancer treatment outcomesA study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...
The tragic death comes after Olympic cycling legend Chris Hoy announced he has terminal prostate cancer aged just 48 ...
Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...
Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback